ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

FoxM1 inhibition ameliorates renal interstitial fibrosis by decreasing extracellular matrix and epithelial-mesenchymal transition

Wang, Yanhui; Zhou, Qiaoling*; Tang, Rong; Huang, Yuyu; He, Ting1
Journal of Pharmacological Sciences2020-8DOI: 10.1016/j.jphs.2020.05.007
13被引12阅读
引用收藏
分享

摘要

FoxM1 is a transcriptional regulator involved in tumor development, pulmonary fibrosis, and cardiac fibrosis. However, its role in renal interstitial fibrosis (RIF) has yet to be elucidated. We established a TGF-beta 1-stimulated human proximal tubular epithelial cell (HK-2) model in vitro and a unilateral ureteral obstruction (UUO)-induced rat RIF model in vivo. FoxM1 inhibition was achieved by siRNA interference in vitro and by injecting thiostrepton into UUO-induced RIF rats in vivo. The degree of renal damage and fibrosis were determined by histological assessment via hematoxylin and eosin (H&E) staining. Immunohistochemistry, western blots, and qPCR were used to determine the expression levels of FoxM1, Collagen I, E-cadherin, alpha-SMA, and Snail1. Our results showed that FoxM1 inhibition could ameliorate RIF and reduce the deposition of Collagen I. H&E staining revealed that renal structural damage, inflammatory cell infiltration, and ECM deposition were significantly attenuated by thiostrepton treatment in the UUO rats. Furthermore, FoxM1 downregulation significantly suppressed epithelial-to-mesenchymal transition, as evidenced by decreased protein and mRNA expression levels of alpha-SMA and Snail1 and a significant increase in protein and mRNA expression levels of E-cadherin. Collectively, these results suggested that FoxM1 inhibition could be a novel therapeutic strategy for the treatment of RIF.

学科与关键词

关键词
FoxM1Renal interstitial fibrosisExtracellular matrix
相关
加载中…
  • Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition
    Zhou, Ruimei; Liao, Jiashun; Cai, Dunpeng; Tian, Qin; Huang, Enping; Lu, Tianming; Chen, Shi-You*; Xie, Wei-Bing*FASEB Journal, 2021, 35(3): e21381.被引 11
  • FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis
    Luo, Jialiang*; Mao, Kaifeng; Zhu, Zhengyumeng; Ye, Junli; Li, Lei; Wang, Di; Zhou, Jia; Lin, Fenwang; Li, Juan*; Ye, Junsheng*Molecular Medicine, 2023, 29(1): 55.被引 1
  • Renal Fibrosis Is Alleviated through Targeted Inhibition of IL-11-Induced Renal Tubular Epithelial-to-Mesenchymal Transition
    Li, Yaqin; Luo, Congwei; Zeng, Yiqun; Zheng, Zerong; Tao, Danping; Liu, Qiao; Hong, Yiyu; Wang, Shuo; Long, Haibo*; Xu, Zhaozhong*American Journal of Pathology, 2023, 193(12): 1936-1952.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Pharmacological Sciences
发表日期
2020-08
卷期
第 143 卷, 第 4 期
页码
281-289
DOI
10.1016/j.jphs.2020.05.007
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81173401, 81470933]; National Natural Science Foundation of China for Youth [81401024]

作者

  • W

    Wang, Yanhui (第一作者)

    1

  • Z

    Zhou, Qiaoling (通讯)

查看全部 5 位作者收起作者
  • T

    Tang, Rong

  • H

    Huang, Yuyu

    1

  • H

    He, Ting

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417